If consumer-grade genetic insights (à la 23andMe) aren’t enough for you, head on over to a deep genomic sequencing clinic. For a hefty price tag, top medical institutions are offering substantially more thorough DNA analyses—but there's plenty of skepticism about targeting healthy clientele and downstream testing costs.
Meanwhile, the NIH’s All of Us program—which aims to make genetic, EHR, and activity data accessible to researchers and patients—reported that 80% of its participants are from groups historically underrepresented in biomedical research. Startup Ciitizen’s Founder and CEO Anil Sethi shared some thoughts with us about putting patients in the driver’s seat of their data. Hear more from him at Rock Health Summit on 9/25 in SF.
Researchers Develop Wearable Fetal Heartbeat Sensor
And they’re doing it with consumer tech MobiHealthNews | (Tweet)
Why A Birth Control Delivery Startup Is Battling With CVS Caremark
It boils down to reimbursement rates and access Business Insider | (Tweet)
Can AI Help Surgeons Assess Traumatic Brain Injuries?
Turning to AI in these cases also raises ethical questions STAT | (Tweet)
Microsoft Adds Samsung's Chief Medical Officer To Health Team
Microsoft’s healthcare strategy: work with, not against, incumbents CNBC | (Tweet)
Inpatient VR Pain Management Study Offers Glimpse At Outcomes
Pain score improvement was significantly better among VR patients MobiHealthNews | (Tweet)
FDA And Syapse To Explore Real-World Treatment Endpoints
The collaboration will focus on the evaluation of targeted cancer therapies FierceBiotech | (Tweet)